[1]
M. Demir, “Effect of bevacizumab, which remain after withdrawal of the first dose/s from a single-use vial on diabetic macular edema”, Int J Basic Clin Pharmacol, vol. 4, no. 1, pp. 159–163, Jan. 2017.